Here's why Eli Lilly is down heading into earnings — and how we plan to play it

  • 📰 CNBC
  • ⏱ Reading Time:
  • 22 sec. here
  • 18 min. at publisher
  • 📊 Quality Score:
  • News: 68%
  • Publisher: 72%

Stock Markets 뉴스

Earnings,Technology,Breaking News: Technology

The Investing Club holds its 'Morning Meeting' every weekday at 10:20 a.m. ET.

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Wednesday's key moments. 1. U.S. stocks advanced Wednesday after breaking the market's three-day losing streak in the previous session. The S & P 500 climbed 1.5%, while the Dow Jones Industrial Average and Nasdaq Composite jumped 1% and 1.9%, respectively. "What we have here today is a good day," Jim Cramer said.

Still, Jim said Eli Lilly shares could fall further after the drugmaker releases its own quarterly results on Thursday. "That's not the end of the world. If it really comes down hard, we will be tempted to buy some," he added. "There's a lot to like about Eli Lilly." 3. Amazon received upbeat news regarding its e-commerce business after CVS Health's quarterly earnings on Wednesday.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 12. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인